CVNACarvana
Carvana Co. is a holding company that was formed as a Delaware corporation in 2016 in order to operate the business of Carvana Group, LLC and its subsidiaries (collectively, "Carvana Group"). 10-K, Item 1
- Employees
- 23,100
- Headquarters
- Tempe, AZ
- CEO
- Ernest C. Garcia III
- Next results
- around Feb 17, 2027
What CVNA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
9 plans still running: Benjamin Huston, Stephen Palmer, Gregory Sullivan, Dan Quayle, Ira Platt, Ryan Keeton.
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Benjamin Huston Company's Chief Operating Officer |
Adopted 10b5-1 plan | Sep 10, 2026 | up to 1,442,565 | Dec 31, 2027 | 10-Q Oct 28, 2026 |
The company's descriptionOn September 10, 2026, Benjamin Huston, the Company's Chief Operating Officer, modified his previously disclosed 10b5-1 Plan to provide for the sale of up to 1,442,565 shares of Class A common stock obtained from the exercise of vested stock options between the first potential sale date of December 10, 2026 and the expiration of the 10b5-1 Plan on December 31, 2027. | |||||
| Stephen Palmer Company's principal accounting officer |
Adopted 10b5-1 plan | Aug 28, 2026 | up to 60,000 | Dec 31, 2027 | 10-Q Oct 28, 2026 |
The company's descriptionOn August 28, 2026, Stephen Palmer, the Company's principal accounting officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"), providing for the potential sale of up to 60,000 shares of Class A common stock between the first potential sale date of January 1, 2027 and the expiration of the 10b5-1 Plan on December 31, 2027. | |||||
| Gregory Sullivan a member of the Company's board of directors |
Adopted 10b5-1 plan | Jun 15, 2026 | up to 142,140 | Apr 20, 2027 | 10-Q Jul 29, 2026 |
The company's descriptionOn June 15, 2026, Gregory Sullivan, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Sullivan's 10b5-1 Plan provides for the potential sale of up to 142,140 shares of Class A common stock, including shares obtained from the exercise of vested stock options, between the first potential sale date of September 14, 2026 and the expiration of the 10b5-1 Plan on April 20, 2027. | |||||
| Thomas Taira Company's President of Special Projects |
Ended 10b5-1 plan | Jun 15, 2026 | up to 200,000 | Dec 31, 2027 | 10-Q Jul 29, 2026 |
The company's descriptionAlso on June 15, 2026, Thomas Taira, the Company's President of Special Projects, modified his previously disclosed 10b5-1 Plan, entered into on July 31, 2025. Mr. Taira's amended 10b5-1 Plan provides for the potential sale of up to 200,000 shares of Class A common stock obtained from the exercise of vested stock options, as well as 100% of any net shares of Class A common stock received, after tax withholding, in connection with certain previously awarded RSUs that vest between July 1, 2026 and December 1, 2027, representing approximately 127,270 RSUs before tax withholding. The sales under Mr. Taira's 10b5-1 Plan may take place between the first potential sale date of September 14, 2026 and the expiration of the 10b5-1 Plan on December 31, 2027. | |||||
| Dan Quayle member of the Company's board of directors, |
Adopted 10b5-1 plan | Mar 11, 2026 | up to 8,714 | Apr 26, 2027 | 10-Q Apr 29, 2026 |
The company's descriptionOn March 11, 2026, Dan Quayle, a member of the Company's board of directors, entered into a 10b5-1 Plan that provides for the sale of up to 8,714 shares of Class A common stock, including shares obtained from the exercise of vested stock options, between the first potential sale date of June 10, 2026 and the expiration of the 10b5-1 Plan on April 26, 2027. | |||||
| Daniel Gill Chief Product Officer |
Ended 10b5-1 plan | Feb 27, 2026 | up to 389,747 | Dec 31, 2028 | 10-Q Apr 29, 2026 |
The company's descriptionOn February 27, 2026, Daniel Gill, the Company's Chief Product Officer, modified his previously disclosed 10b5-1 Plan, entered into on December 13, 2024. Mr. Gill's amended 10b5-1 Plan provides for the potential sale of up to 389,747 shares of Class A common stock, including shares obtained from the exercise of vested stock options and shares obtained from the conversion of Carvana Group, LLC Class B common units into shares of Class A common stock, between the first potential sale date of May 29, 2026 and the expiration of the 10b5-1 Plan on December 31, 2028. | |||||
| Ira Platt member of the Company's board of directors |
Adopted 10b5-1 plan | Feb 20, 2026 | up to 10,027 | Feb 15, 2027 | 10-Q Apr 29, 2026 |
The company's descriptionOn February 20, 2026, Ira Platt, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Platt's 10b5-1 Plan provides for the potential sale of up to 10,027 shares of Class A common stock between the first potential sale date of May 22, 2026 and the expiration of the 10b5-1 Plan on February 15, 2027. | |||||
| Ryan Keeton Chief Brand Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | up to 38,000 | Dec 31, 2026 | 10-K Feb 18, 2026 |
The company's descriptionOn December 15, 2025, Ryan Keeton, the Company's Chief Brand Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Keeton's 10b5-1 Plan provides for the sale of up to 38,000 shares of Class A common stock between the first potential sale date of March 16, 2026 and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Tom Taira Company's President of Special Projects |
Ended 10b5-1 plan | Jul 31, 2025 | up to 85,000 | Jun 30, 2027 | 10-Q Oct 29, 2025 |
The company's descriptionOn July 31, 2025, Tom Taira, the Company's President of Special Projects, terminated his previously disclosed trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"), entered into on December 3, 2024. Mr. Taira entered into a new 10b5-1 Plan on August 8, 2025 that provides for the potential sale of up to 85,000 shares of Class A common stock, including shares obtained from the exercise of vested stock options, between the first potential sale date of November 7, 2025 and the expiration of the 10b5-1 Plan on June 30, 2027. | |||||
| Paul Breaux Vice President, General Counsel, Secretary, and Chief Compliance Officer |
Ended 10b5-1 plan | Jun 10, 2025 | up to 110,000 | Dec 31, 2027 | 10-Q Jul 30, 2025 |
The company's descriptionOn June 10, 2025, Paul Breaux, the Company's Vice President, General Counsel, Secretary, and Chief Compliance Officer modified a previously adopted 10b5-1 Plan. The previously adopted 10b5-1 Plan was entered into on June 9, 2023, was set to expire on December 31, 2025, and provided for the potential sale of up to 445,000 shares of Class A common stock, including shares obtained from the exercise of vested stock options and the conversion of Carvana Group's Class B Units into shares of the Company's Class A common stock. Mr. Breaux's modified 10b5-1 Plan provides for the potential sale of up to 110,000 shares of Class A common stock, including shares obtained from the exercise of vested stock options, between the first potential sale date on September 9, 2025 and the expiration of the 10b5-1 Plan on December 31, 2027. | |||||
| Ira Platt member of the Company's board of directors |
Adopted 10b5-1 plan | Jun 2, 2025 | up to 14,000 | Dec 31, 2026 | 10-Q Jul 30, 2025 |
The company's descriptionOn June 2, 2025, after completion of all sales under his previous trading plan and its resulting natural expiration, Ira Platt, a member of the Company's board of directors, entered into a 10b5-1 Plan providing for the potential sale of up to 14,000 shares of Class A common stock, between the first potential sale date on September 10, 2025 and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Michael Maroone member of the Company's board of directors |
Adopted 10b5-1 plan | May 30, 2025 | up to 30,928 | Feb 27, 2026 | 10-Q Jul 30, 2025 |
The company's descriptionOn May 30, 2025, Michael Maroone, a member of the Company's board of directors, entered into a 10b5-1 Plan providing for the potential sale of up to 30,928 shares of Class A common stock obtained from the exercise of vested stock options between the first potential sale date on August 29, 2025 and the expiration of the 10b5-1 Plan on February 27, 2026. | |||||
| Stephen Palmer Vice President, Accounting and Finance, |
Adopted 10b5-1 plan | May 28, 2025 | up to 15,000 | Nov 30, 2026 | 10-Q Jul 30, 2025 |
The company's descriptionOn May 28, 2025, Stephen Palmer, the Company's Vice President, Accounting and Finance, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Palmer's 10b5-1 Plan provides for the potential sale of up to 15,000 shares of Class A common stock between the first potential sale date of September 1, 2025 and the expiration of the 10b5-1 Plan on November 30, 2026. | |||||
| Gregory Sullivan member of the Company's board of directors |
Adopted 10b5-1 plan | Mar 11, 2025 | up to 5,000 | Mar 31, 2026 | 10-Q May 7, 2025 |
The company's descriptionOn March 11, 2025, after completion of all sales under his previous trading plan and its resulting expiration, Gregory Sullivan, a member of the Company's board of directors, entered into a 10b5-1 Plan. Mr. Sullivan's 10b5-1 Plan provides for the potential sale of up to 5,000 shares of Class A common stock, between the first potential sale date on June 10, 2025 and the expiration of the 10b5-1 Plan on March 31, 2026. | |||||
| Ira Platt a member of the Company's board of directors |
Adopted 10b5-1 plan | Mar 6, 2025 | up to 5,674 | Dec 31, 2026 | 10-Q May 7, 2025 |
The company's descriptionOn March 6, 2025, after completion of all sales under his previous trading plan and its resulting expiration, Ira Platt, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Platt's 10b5-1 Plan provides for the potential sale of up to 5,674 shares of Class A common stock, between the first potential sale date on June 5, 2025 and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Benjamin Huston Company's Chief Operating Officer |
Ended 10b5-1 plan | Dec 13, 2024 | up to 608,495 | Dec 31, 2026 | 10-K Feb 19, 2025 |
The company's descriptionOn December 13, 2024, Benjamin Huston, the Company's Chief Operating Officer, modified a previously adopted 10b5-1 Plan. The previously adopted 10b5-1 Plan was entered into on March 16, 2021, was set to expire on December 31, 2024, and provided for the potential sale of up to approximately 499,973 shares of Class A common stock, including shares obtained from the conversion of Carvana Group, LLC Class B common units into shares of Class A common stock. Mr. Huston's modified 10b5-1 Plan provides for the potential sale of up to 608,495 shares of Class A common stock, including shares obtained through the exercise of vested stock options and shares obtained from the conversion of Carvana Group, LLC Class B common units into shares of Class A common stock, between the first potential sale date on March 14, 2025, and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Ernest Garcia III Chief Executive Officer |
Adopted 10b5-1 plan | Dec 13, 2024 | up to 1,000,000 | Mar 16, 2026 | 10-K Feb 19, 2025 |
The company's descriptionOn December 13, 2024, Ernest Garcia III, the Company's Chief Executive Officer, entered into a 10b5-1 Plan providing for the potential sale of up to 1,000,000 shares of Class A common stock between the first potential sale date on March 14, 2025, and the expiration of the 10b5-1 Plan on March 16, 2026. | |||||
| Daniel Gill Company's Chief Product Officer |
Ended 10b5-1 plan | Dec 11, 2024 | up to 515,166 | Dec 31, 2026 | 10-K Feb 19, 2025 |
The company's descriptionOn December 11, 2024, Daniel Gill, the Company's Chief Product Officer, terminated his previously disclosed 10b5-1 Plan, entered into on June 14, 2023. On December 13, 2024, Mr. Gill entered into a new 10b5-1 Plan, providing for the potential sale of up to 515,166 shares of Class A common stock, including shares obtained through the exercise of vested stock options, between the first potential sale date on March 14, 2025, and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Tom Taira Company's President of Special Projects |
Adopted 10b5-1 plan | Dec 3, 2024 | up to 128,471 | Dec 31, 2025 | 10-K Feb 19, 2025 |
The company's descriptionOn December 3, 2024, Tom Taira, the Company's President of Special Projects, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Taira's 10b5-1 Plan provides for the potential sale of up to 128,471 shares of Class A common stock, including shares obtained through the exercise of vested stock options, between the first potential sale date on March 4, 2025 and the expiration of the 10b5-1 Plan on December 31, 2025. | |||||
| Ira Platt a member of the Company's board of directors |
Adopted 10b5-1 plan | Sep 10, 2024 | up to 25,000 | Sep 1, 2026 | 10-Q Oct 30, 2024 |
The company's descriptionOn September 10, 2024, after completion of all sales under his previous trading plan and its resulting expiration, Ira Platt, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Platt's 10b5-1 Plan provides for the potential sale of up to 25,000 shares of Class A common stock, including shares obtained from the conversion of Carvana Group, LLC Class B common units, between the first potential sale date on December 10, 2024 and the expiration of the 10b5-1 Plan on September 1, 2026. | |||||
| Mark Jenkins the Company's Chief Financial Officer |
Ended 10b5-1 plan | Aug 5, 2024 | up to 824,417 | Dec 31, 2026 | 10-Q Oct 30, 2024 |
The company's descriptionOn August 5, 2024, Mark Jenkins, the Company's Chief Financial Officer, terminated his previously disclosed 10b5-1 Plan, entered into on December 15, 2023. On the same date Mr. Jenkins entered into a new 10b5-1 Plan, providing for the potential sale of up to 824,417 shares of Class A common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan and obtained from the conversion of Carvana Group, LLC Class B common units into shares of Class A common stock, between the first potential sale date on November 4, 2024 and the expiration of the 10b5-1 Plan on December 31, 2026. | |||||
| Tom Taira President of Special Products |
Ended 10b5-1 plan | Jun 24, 2024 | up to 133,556 | Dec 31, 2025 | 10-Q Jul 31, 2024 |
The company's descriptionOn June 24, 2024, Tom Taira, the Company's President of Special Products, terminated his previously adopted 10b5-1 Plan. Mr. Taira's 10b5-1 Plan was entered into on March 15, 2024, was set to expire on December 31, 2025, and provided for the potential sale of up to 133,556 shares of Class A common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan | |||||
| Ira Platt a member of the Company's board of directors |
Adopted 10b5-1 plan | May 9, 2024 | up to 25,180 | Dec 31, 2025 | 10-Q Jul 31, 2024 |
The company's descriptionOn May 9, 2024, Ira Platt, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Platt's 10b5-1 Plan provides for the potential sale of up to 25,180 shares of Class A common stock between the first potential sale date on August 8, 2024 and the expiration of the 10b5-1 Plan on December 31, 2025. | |||||
| Gregory Sullivan a member of the Company's board of directors |
Ended 10b5-1 plan | May 6, 2024 | up to 5,000 | May 31, 2025 | 10-Q Jul 31, 2024 |
The company's descriptionOn May 6, 2024, Gregory Sullivan, a member of the Company's board of directors, terminated his previously adopted 10b5-1 Plan. Mr. Sullivan's 10b5-1 Plan was entered into on March 14, 2024, was set to expire on May 31, 2025, and provided for the potential sale of up to 5,000 shares of Class A common stock. | |||||
| Tom Taira President of Special Products |
Adopted 10b5-1 plan | Mar 15, 2024 | up to 133,556 | 565 days | 10-Q May 1, 2024 |
The company's descriptionOn March 15, 2024, Tom Taira, the Company's President of Special Products, entered into a 10b5-1 Plan. Mr. Taira's 10b5-1 Plan provides for the potential sale of up to 133,556 shares of Class A common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between the first potential sale date on June 14, 2024 and the expiration of the 10b5-1 Plan on December 31, 2025. | |||||
| Gregory Sullivan member of the Company's board of directors |
Adopted 10b5-1 plan | Mar 14, 2024 | up to 5,000 | 352 days | 10-Q May 1, 2024 |
The company's descriptionOn March 14, 2024, Gregory Sullivan, a member of the Company's board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Sullivan's 10b5-1 Plan provides for the potential sale of up to 5,000 shares of Class A common stock between the first potential sale date on June 13, 2024 and the expiration of the 10b5-1 Plan on May 31, 2025. | |||||
| Mark Jenkins Company's Chief Financial Officer |
Adopted 10b5-1 plan | Dec 15, 2023 | up to 310,000 | 640 days | 10-K Feb 22, 2024 |
The company's descriptionOn December 15, 2023, Mark Jenkins, the Company's Chief Financial Officer, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a "10b5-1 Plan"). Mr. Jenkins's 10b5-1 Plan was adopted on March 15, 2021 and provided for the potential sale of up to 499,965 shares of Class A common stock, including shares obtained from the conversion of Carvana Group, LLC Class B common units into shares of Class A common stock. Following the termination of the previous 10b5-1 Plan, on December 15, 2023, Mr. Jenkins entered into a new 10b5-1 Plan, which provides for the potential sale of up to 310,000 shares of Class A common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan between on or after March 15, 2024 and December 31, 2025. | |||||
| Stephen Palmer Vice President of Accounting and Finance |
Adopted 10b5-1 plan | Nov 8, 2023 | up to 15,000 | 183 days | 10-K Feb 22, 2024 |
The company's descriptionOn November 8, 2023, Stephen Palmer, the Company's Vice President of Accounting and Finance, entered into a 10b5-1 Plan. Mr. Palmer's 10b5-1 Plan provides for the potential sale of up to 15,000 shares of Class A common stock between on or after March 1, 2024 and August 31, 2024. | |||||
| Daniel Gill Chief Product Officer |
Adopted 10b5-1 plan | Jun 14, 2023 | up to 432,522 | – | 10-Q Jul 19, 2023 |
The company's descriptionDaniel Gill, the Company's Chief Product Officer entered into a 10b5-1 Plan. Mr. Gill's 10b5-1 Plan provides for the potential sale of up to 432,522 shares of Class A common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between September 13, 2023 and August 31, 2025. | |||||
| Paul Breaux Vice President, General Counsel, and Secretary |
Adopted plan | Jun 9, 2023 | up to 445,000 | – | 10-Q Jul 19, 2023 |
The company's description10b5-1 Plan"). Mr. Breaux's 10b5-1 Plan was adopted on June 11, 2022 and provided for the potential sale of up to 105,000 shares of Class A common stock, including shares obtained from the conversion of Carvana Group, LLC Class B common units (the "B Units") into shares of Class A common stock. Following the termination of the previous 10b5-1 Plan, on June 9, 2023. Mr. Breaux also entered into a new 10b5-1 Plan. Mr. Breaux's new 10b5-1 Plan provides for the potential sale of up to 445,000 shares of Class A common stock, including shares obtained from the exercise of vested stock options and the conversion of B Units covered by the 10b5-1 Plan, between September 8, 2023 and December 31, 2025. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 14 filings checked since Jul 19, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | THOMAS TAIRA Officer |
5,596 | $411,698 | Restricted Stock Units | adopted Jun 15, 2026 | none found |
| Nov 4, 2026 | IRA PLATT Director |
29,640 | $2,245,114 | Exercise of Options Under a Registered Plan | none given | 29,640 shares from Nov 4, 2026 |
| Nov 3, 2026 | DANIEL AND LIAN GILL FAMILY TRUST Officer |
253,639 | $18,123,902 | Restricted Stock Vesting Under a Registered Plan | none given | 253,639 shares from Nov 3, 2026 |
| Nov 3, 2026 | IRA PLATT Director |
30,000 | $2,152,227 | Exercise of Options Under a Registered Plan | none given | 59,640 shares from Nov 3, 2026 |
| Nov 2, 2026 | MARK JENKINS Officer |
63,750 | $4,353,488 | Exercise of Stock Options | adopted Aug 5, 2024 | 63,750 shares from Nov 2, 2026 |
| Oct 30, 2026 | JAMES DANFORTH QUAYLE Director |
14,520 | $1,000,084 | Exercise of Options Under a Registered Plan | none given | 14,520 shares from Oct 30, 2026 |
| Oct 30, 2026 | GARCIA ERNEST C. II 10% Stockholder |
10,000,000 | $682,900,000 | Conversion - Exchange of Units | none given | none found |
| Oct 13, 2026 | THOMAS TAIRA Officer |
5,597 | $356,697 | Restricted Stock Units | adopted Jun 15, 2026 | none found |
| Oct 1, 2026 | MARK JENKINS Officer |
63,750 | $3,986,925 | Exercise of Stock Options | adopted Aug 5, 2024 | 63,750 shares from Oct 1, 2026 |
| Sep 14, 2026 | THOMAS TAIRA Officer |
16,789 | $1,161,127 | Restricted Stock Units | adopted Jun 15, 2026 | 22,386 shares from Sep 14, 2026 |
| Sep 1, 2026 | BHJC Trust Officer |
50,000 | $3,673,000 | Restricted Stock Units | adopted Dec 13, 2024 | none found |
| Sep 1, 2026 | MARK JENKINS Officer |
63,750 | $4,683,075 | Exercise of Stock Options | adopted Aug 5, 2024 | 127,500 shares from Sep 1, 2026 |
| Aug 14, 2026 | JAMES DANFORTH QUAYLE Director |
14,525 | $1,070,492 | Exercise of Stock Options | adopted Mar 11, 2026 | 14,525 shares from Aug 14, 2026 |
| Aug 14, 2026 | IRA PLATT Director |
15,000 | $1,132,500 | Exercise of Options Under a Registered Plan | none given | 15,000 shares from Aug 14, 2026 |
| Aug 13, 2026 | IRA PLATT Director |
15,000 | $1,095,000 | Exercise of Options Under a Registered Plan | none given | 30,000 shares from Aug 13, 2026 |
| Aug 3, 2026 | BHJC Trust Officer |
50,000 | $3,118,000 | Performance Stock Units; Restricted Stock Units | adopted Dec 13, 2024 | none found |
| Aug 3, 2026 | MARK JENKINS Officer |
63,750 | $3,975,450 | Exercise of Stock Options | adopted Aug 5, 2024 | 127,500 shares from Aug 3, 2026 |
| Jul 1, 2026 | MARK JENKINS Officer |
63,750 | $4,196,025 | Exercise of Stock Options | adopted Aug 5, 2024 | 63,750 shares from Jul 1, 2026 |
| Jul 1, 2026 | BHJC Trust Officer |
50,000 | $3,291,000 | Restricted and Performance Stock Units | adopted Dec 13, 2024 | none found |
| Jun 15, 2026 | IRA PLATT Director |
15,000 | $1,017,375 | Exercise of Options Under a Registered Plan | none given | 15,000 shares from Jun 15, 2026 |
| Jun 10, 2026 | JAMES DANFORTH QUAYLE Director |
14,525 | $1,011,085 | Exercise of Stock Options | adopted Mar 11, 2026 | 14,525 shares from Jun 10, 2026 |
| Jun 8, 2026 | THOMAS TAIRA Officer |
5,597 | $372,256 | Restricted Stock Units | adopted Aug 8, 2025 | 5,597 shares from Jun 8, 2026 |
| Jun 1, 2026 | BHJC Trust Officer |
50,000 | $3,650,000 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Jun 1, 2026 | MARK JENKINS Officer |
63,750 | $4,653,750 | Exercise of Stock Options | adopted Aug 5, 2024 | 127,500 shares from Jun 1, 2026 |
| May 8, 2026 | THOMAS TAIRA Officer |
5,590 | $2,236,112 | Restricted Stock Units | adopted Aug 8, 2025 | 5,590 shares from May 8, 2026 |
| May 1, 2026 | BHJC Trust Officer |
10,000 | $3,958,000 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| May 1, 2026 | MARK JENKINS Officer |
12,750 | $5,046,450 | Exercise of Stock Options | adopted Aug 5, 2024 | 12,750 shares from May 1, 2026 |
| May 1, 2026 | GARCIA ERNEST C. II 10% Stockholder |
4,000,000 | $1,583,200,000 | Conversion - Exchange of Units | none given | none found |
| Apr 8, 2026 | THOMAS TAIRA Officer |
3,770 | $1,207,229 | Restricted Stock Units | adopted Aug 8, 2025 | 5,590 shares from May 8, 2026 |
| Apr 1, 2026 | BHJC Trust Officer |
10,000 | $3,143,800 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Apr 1, 2026 | MARK JENKINS Officer |
12,750 | $4,008,345 | Exercise of Stock Options | adopted Aug 5, 2024 | 12,750 shares from May 1, 2026 |
| Mar 9, 2026 | THOMAS TAIRA Officer |
953 | $302,768 | Restricted Stock Units | adopted Aug 8, 2025 | none found |
| Mar 9, 2026 | JAMES DANFORTH QUAYLE Director |
2,900 | $898,913 | Exercise of options under a registered plan | none given | none found |
| Mar 2, 2026 | BHJC Trust Officer |
10,000 | $3,341,600 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Mar 2, 2026 | MARK JENKINS Officer |
12,750 | $4,260,540 | Exercise of Stock Options | adopted Aug 5, 2024 | none found |
| Feb 9, 2026 | THOMAS TAIRA Officer |
1,047 | $422,642 | Restricted Stock Units | adopted Aug 8, 2025 | none found |
| Feb 2, 2026 | MARK JENKINS Officer |
12,750 | $5,114,152 | Exercise of Stock Options | adopted Aug 5, 2024 | none found |
| Feb 2, 2026 | BHJC Trust Officer |
10,000 | $4,011,100 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Jan 8, 2026 | THOMAS TAIRA Officer |
1,174 | $529,216 | Restricted Stock Units | adopted Aug 8, 2025 | none found |
| Jan 2, 2026 | BHJC Trust Officer |
10,000 | $4,220,200 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Jan 2, 2026 | MARK JENKINS Officer |
12,750 | $5,380,755 | Exercise of Stock Options | adopted Aug 5, 2024 | none found |
| Dec 12, 2025 | THOMAS TAIRA Officer |
10,000 | $4,727,300 | Exercise of Stock Options | adopted Aug 8, 2025 | none found |
| Dec 12, 2025 | PAUL BREAUX Officer |
1,527 | $721,859 | Exercise of Stock Options | adopted Jun 10, 2025 | none found |
| Dec 12, 2025 | DANIEL & LIAN GILL FAMILY TRUST Officer |
40,000 | $18,909,200 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Dec 12, 2025 | BHJC Trust Officer |
20,000 | $9,454,600 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Dec 11, 2025 | PAUL BREAUX Officer |
8,473 | $3,962,568 | Exercise of Stock Options | adopted Jun 10, 2025 | none found |
| Dec 8, 2025 | DANIEL & LIAN GILL FAMILY TRUST Officer |
80,000 | $31,981,600 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Dec 8, 2025 | BHJC Trust Officer |
40,000 | $15,990,800 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Dec 8, 2025 | PAUL BREAUX Officer |
20,000 | $7,995,400 | Exercise of Stock Options; Restricted and Performance Stock Units | adopted Jun 10, 2025 | none found |
| Dec 8, 2025 | THOMAS TAIRA Officer |
30,952 | $12,373,681 | Exercise of Stock Options; Restricted and Performance Stock Units | adopted Aug 8, 2025 | none found |
| Dec 3, 2025 | Michael E. Maroone Director |
30,928 | $12,216,560 | Acquired upon option exercise | adopted May 30, 2025 | none found |
| Dec 3, 2025 | THOMAS TAIRA Officer |
25,000 | $9,554,500 | Restricted and Performance Stock Units | adopted Aug 8, 2025 | none found |
| Dec 1, 2025 | MARK JENKINS Officer |
12,750 | $4,774,875 | Exercise of Stock Options | adopted Aug 5, 2024 | none found |
| Dec 1, 2025 | BHJC Trust Officer |
10,000 | $3,745,000 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Nov 28, 2025 | THOMAS TAIRA Officer |
10,000 | $3,573,300 | RSUs/PSUs | adopted Aug 8, 2025 | none found |
| Nov 12, 2025 | GREGORY B SULLIVAN REVOCABLE TRUST Director |
2,500 | $850,000 | Restricted stock vesting under a registered plan | none given | none found |
| Nov 10, 2025 | THOMAS TAIRA Officer |
952 | $289,398 | Restricted Stock Units | adopted Aug 8, 2025 | none found |
| Nov 4, 2025 | GREGORY B SULLIVAN REVOCABLE TRUST Director |
2,500 | $805,507 | Restricted stock vesting under a registered plan | none given | none found |
| Nov 3, 2025 | BHJC Trust Officer |
10,000 | $3,065,400 | Exercise of Stock Options | adopted Dec 13, 2024 | none found |
| Nov 3, 2025 | MARK JENKINS Officer |
12,750 | $3,908,385 | Exercise of Stock Options | adopted Aug 5, 2024 | none found |
| Oct 31, 2025 | RYAN AND LAUREN KEETON FAMILY TRUST Officer |
32,370 | $9,765,408 | Exercise of options under a registered plan; Restricted stock vesting under a registered plan | none given | none found |
| Oct 31, 2025 | KEETON RYAN S. Officer |
40,000 | $12,237,080 | Open Market Purchase in Public Market | none given | none found |
From the Form 144 XML filed with the SEC, since Oct 31, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on CVNA in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CVNA/export.csv") into a cell.